vs
和黄医药（HCM）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
和黄医药的季度营收约是Rapid7, Inc.的1.2倍（$270.8M vs $217.4M），Rapid7, Inc.净利率更高（1.4% vs 0.7%，领先0.7%），Rapid7, Inc.同比增速更快（0.5% vs -16.5%），Rapid7, Inc.自由现金流更多（$36.4M vs $3.4M）
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
HCM vs RPD — 直观对比
营收规模更大
HCM
是对方的1.2倍
$217.4M
营收增速更快
RPD
高出17.1%
-16.5%
净利率更高
RPD
高出0.7%
0.7%
自由现金流更多
RPD
多$33.1M
$3.4M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.8M | $217.4M |
| 净利润 | $2.0M | $3.1M |
| 毛利率 | 37.7% | 68.9% |
| 营业利润率 | -13.2% | 1.0% |
| 净利率 | 0.7% | 1.4% |
| 营收同比 | -16.5% | 0.5% |
| 净利润同比 | -83.6% | 44.1% |
| 每股收益（稀释后） | $0.00 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HCMRPD
| Q4 25 | $270.8M | $217.4M | ||
| Q3 25 | — | $218.0M | ||
| Q2 25 | $277.7M | $214.2M | ||
| Q1 25 | $324.5M | $210.3M | ||
| Q4 24 | — | $216.3M | ||
| Q3 24 | — | $214.7M | ||
| Q2 24 | $305.7M | $208.0M | ||
| Q1 24 | — | $205.1M |
净利润HCMRPD
| Q4 25 | $2.0M | $3.1M | ||
| Q3 25 | — | $9.8M | ||
| Q2 25 | $455.0M | $8.3M | ||
| Q1 25 | $11.9M | $2.1M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | — | $15.4M | ||
| Q2 24 | $25.8M | $6.5M | ||
| Q1 24 | — | $1.4M |
毛利率HCMRPD
| Q4 25 | 37.7% | 68.9% | ||
| Q3 25 | — | 70.2% | ||
| Q2 25 | 0.1% | 70.6% | ||
| Q1 25 | 48.0% | 71.7% | ||
| Q4 24 | — | 69.5% | ||
| Q3 24 | — | 70.6% | ||
| Q2 24 | 41.1% | 70.7% | ||
| Q1 24 | — | 70.3% |
营业利润率HCMRPD
| Q4 25 | -13.2% | 1.0% | ||
| Q3 25 | — | 2.7% | ||
| Q2 25 | -1.3% | 1.6% | ||
| Q1 25 | -5.0% | -0.0% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | -9.0% | 2.5% | ||
| Q1 24 | — | 4.7% |
净利率HCMRPD
| Q4 25 | 0.7% | 1.4% | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | 163.8% | 3.9% | ||
| Q1 25 | 3.7% | 1.0% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 7.2% | ||
| Q2 24 | 8.4% | 3.1% | ||
| Q1 24 | — | 0.7% |
每股收益（稀释后）HCMRPD
| Q4 25 | $0.00 | $0.05 | ||
| Q3 25 | — | $0.15 | ||
| Q2 25 | $0.52 | $0.13 | ||
| Q1 25 | $0.01 | $0.03 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.21 | ||
| Q2 24 | $0.03 | $0.09 | ||
| Q1 24 | — | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $474.7M |
| 总债务越低越好 | $93.2M | — |
| 股东权益账面价值 | $1.2B | $154.7M |
| 总资产 | $1.8B | $1.7B |
| 负债/权益比越低杠杆越低 | 0.08× | — |
8季度趋势，按日历期对齐
现金及短期投资HCMRPD
| Q4 25 | $1.4B | $474.7M | ||
| Q3 25 | — | $407.1M | ||
| Q2 25 | $1.4B | $511.7M | ||
| Q1 25 | $836.1M | $493.5M | ||
| Q4 24 | — | $521.7M | ||
| Q3 24 | — | $443.7M | ||
| Q2 24 | $802.5M | $442.6M | ||
| Q1 24 | — | $411.7M |
总债务HCMRPD
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
股东权益HCMRPD
| Q4 25 | $1.2B | $154.7M | ||
| Q3 25 | — | $127.2M | ||
| Q2 25 | $1.2B | $90.4M | ||
| Q1 25 | $759.9M | $52.7M | ||
| Q4 24 | — | $17.7M | ||
| Q3 24 | — | $-5.1M | ||
| Q2 24 | $740.1M | $-52.6M | ||
| Q1 24 | — | $-86.4M |
总资产HCMRPD
| Q4 25 | $1.8B | $1.7B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | $1.8B | $1.6B | ||
| Q1 25 | $1.3B | $1.6B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | $1.3B | $1.5B | ||
| Q1 24 | — | $1.5B |
负债/权益比HCMRPD
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.2M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $3.4M | $36.4M |
| 自由现金流率自由现金流/营收 | 1.2% | 16.8% |
| 资本支出强度资本支出/营收 | 1.8% | 0.5% |
| 现金转化率经营现金流/净利润 | 4.21× | 12.01× |
| 过去12个月自由现金流最近4个季度 | $-96.2M | $146.2M |
8季度趋势，按日历期对齐
经营现金流HCMRPD
| Q4 25 | $8.2M | $37.6M | ||
| Q3 25 | — | $39.0M | ||
| Q2 25 | $-72.9M | $47.5M | ||
| Q1 25 | $40.3M | $29.8M | ||
| Q4 24 | — | $63.8M | ||
| Q3 24 | — | $44.0M | ||
| Q2 24 | $-39.8M | $32.9M | ||
| Q1 24 | — | $31.1M |
自由现金流HCMRPD
| Q4 25 | $3.4M | $36.4M | ||
| Q3 25 | — | $34.8M | ||
| Q2 25 | $-82.2M | $46.6M | ||
| Q1 25 | $32.5M | $28.4M | ||
| Q4 24 | — | $62.6M | ||
| Q3 24 | — | $42.6M | ||
| Q2 24 | $-49.9M | $32.6M | ||
| Q1 24 | — | $30.4M |
自由现金流率HCMRPD
| Q4 25 | 1.2% | 16.8% | ||
| Q3 25 | — | 16.0% | ||
| Q2 25 | -29.6% | 21.8% | ||
| Q1 25 | 10.0% | 13.5% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | — | 19.9% | ||
| Q2 24 | -16.3% | 15.7% | ||
| Q1 24 | — | 14.8% |
资本支出强度HCMRPD
| Q4 25 | 1.8% | 0.5% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | 3.3% | 0.4% | ||
| Q1 25 | 2.4% | 0.6% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | 3.3% | 0.1% | ||
| Q1 24 | — | 0.3% |
现金转化率HCMRPD
| Q4 25 | 4.21× | 12.01× | ||
| Q3 25 | — | 3.97× | ||
| Q2 25 | -0.16× | 5.70× | ||
| Q1 25 | 3.38× | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | -1.54× | 5.03× | ||
| Q1 24 | — | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HCM
暂无分部数据
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
